Quality indicators for colorectal cancer care

Quality can and should be measured

Through the accreditation process, quality is measured by compliance with standards. These standards are developed by national experts in colon and rectal cancer. They measure how well a program delivers the treatments that are proven to work the best. 

See this information in graph form

The table below shows that Legacy Cancer Institute outperforms other cancer programs on key quality benchmarks, established by the American College of Surgeons Commission on Cancer (CoC). It also shows the percent of our colorectal cancer patients treated according to the highest, nationally recognized standards of care developed through the Commission on Cancer. Legacy's exceptional performance, shown in our high numbers, are evidence that our patients receive the most up-to-date and effective treatment.

Legacy Cancer Institute outperforms its peers in important treatment areas

For patients with colon cancer    

Legacy Cancer Institute 

State of Oregon 

Pacific NW Region 

All CoC approved programs 

Commission on Cancer standard 

Adjuvant chemotherapy is considered or administered within four months of diagnosis for patients under age 80 with AJCC Stage III (lymph node positive) colon cancer 

100% 

93% 

80.3% 

84.9% 

100% 

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer 

94.7% 

90.2% 

88% 

87.8% 

100% 

For patients with rectal cancer 

         

Radiation therapy is considered or administered within six months of diagnosis for patients under age 80 with clinical or pathologic AJCC T4NOMO or Stage III receiving surgical resection for rectal cancer

100% 

96.6% 

88.4% 

90.4% 

100%